Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals

Details 詳細情報について

• CRID

  1363951795739350144

• DOI

  10.1016/j.addr.2020.07.024

• ISSN

  0169409X

• Web Site

  https://api.elsevier.com/content/article/PII:S0169409X20301083?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0169409X20301083?httpAccept=text/plain

• Data Source

  • Crossref